Kwang-Woong Lee

Prof. Dr. Kwang-Woong Lee

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2016 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
KLKwang-Woong Lee
Kwang-Woong Lee
SSSuk‐Won Suh
Suk‐Won Suh
YCYoungRok Choi
YoungRok Choi
JJJaehong Jeong
Jaehong Jeong
NYNam‐Joon Yi
Nam‐Joon Yi
KSKyung‐Suk Suh
Kyung‐Suk Suh
The indication of liver transplantation (LT) for the treatment of advanced hepatocellular carcinoma (HCC) is expanding. However, portal vein tumor thrombus (PVTT) has been still accepted as an absolute contraindication. We experienced an unexpectedly good prognosis in selected patients. Therefore, we tried to identify the prognostic factors after LT for HCC with major PVTT. Among 282 patients who underwent living donor liver transplantation (LDLT) for HCC from January 2009 to December 2013, 11 (3.9%) patients with major PVTT that was preoperatively diagnosed were investigated. The 1‐, 3‐, and 5‐year recurrence‐free survival rates were 63.6%, 45.5%, and 45.5%, respectively, and all recurrent cases showed intrahepatic and extrahepatic recurrence. The 1‐, 3‐, and 5‐year overall survival rates were 72.7%, 63.6%, and 63.6%, respectively, and 2 patients with delayed recurrence survived approximately 5 years after LT. Main portal vein (PV) invasion (P < 0.01), high alpha‐fetoprotein × protein induced by vitamin K absence/antagonist‐II (AP) score (≥20,000; P < 0.01), high standardized uptake value (SUV) ratio (tumor/background liver) in positron emission tomography (≥2.1; P < 0.01), and a large original tumor (≥7 cm; P = 0.03) were significant risk factors for recurrence. In conclusion, if the PVTT has not expanded to the main PV and the AP score is not high, we can consider LDLT as a curative treatment option. Liver Transplantation 23:19–27 2017 AASLD.

9 December 2016 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
SHSuk Kyun Hong
Suk Kyun Hong
KLKwang-Woong Lee
Kwang-Woong Lee
HKHyo‐Sin Kim
Hyo‐Sin Kim
KYKyung Chul Yoon
Kyung Chul Yoon
SASung Woo Ahn
Sung Woo Ahn
KSKyung‐Suk Suh
Kyung‐Suk Suh

22 December 2014 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
SSSuk‐Won Suh
Suk‐Won Suh
KLKwang-Woong Lee
Kwang-Woong Lee
JLJeong‐Moo Lee
Jeong‐Moo Lee
YCYoungRok Choi
YoungRok Choi
NYNam-Joon Yi
Nam-Joon Yi
KSKyung Su Suh
Kyung Su Suh

31 December 2021 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
KLKwang-Woong Lee
Kwang-Woong Lee
YCYoungRok Choi
YoungRok Choi
SHSuk Kyun Hong
Suk Kyun Hong
Nam-Joon YiNam-Joon Yi
Nam-Joon Yi
SHSu Young Hong
Su Young Hong
KSKyung Su Suh
Kyung Su Suh
Minimally invasive surgery has been introduced for liver transplantations. Although laparoscopic or robot-assisted living donor hepatectomy is being used, minimally invasive surgery is rarely performed in recipients during liver transplantation. A 63-year-old patient (body mass index: 21.9 kg/m2) with primary biliary cirrhosis underwent total laparoscopic explant hepatectomy, followed by robot-assisted liver engraftment using advanced technological innovations. The total operation time for the recipient was 12 h 20 min, including laparoscopic explant hepatectomy (140 min) and robot-assisted engraftment (220 min). Achieving hepatic and portal vein anastomoses consumed 35 min and 28 min, respectively. The hepatic artery anastomosis and bile duct reconstruction took 83 min and 66 min, respectively. The estimated blood loss was 3,600 ml. The warm and cold ischemic times were 87 and 220 min, respectively. The patient received 10 units each of red blood cells and fresh frozen plasma during the surgery and recovered from early allograft dysfunction after liver transplantation. This case study suggests that laparoscopic explant hepatectomy followed by robot-assisted engraftment is feasible in selected recipients only. We obtained informed consent for this innovative procedure from the patient and from her living donor.

31 July 2021 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
KSKyung Su Suh
Kyung Su Suh
SHSuk Kyun Hong
Suk Kyun Hong
SLSola Lee
Sola Lee
SHSu Young Hong
Su Young Hong
SSSanggyun Suh
Sanggyun Suh
KLKwang-Woong Lee
Kwang-Woong Lee
Minimally invasive approaches are increasingly being applied in surgeries and have recently been used in living donor hepatectomy. We have developed a safe and reproducible method for minimally invasive living donor liver transplantation, which consists of pure laparoscopic explant hepatectomy and pure laparoscopic implantation of the graft, which was inserted through a suprapubic incision. Pure laparoscopic explant hepatectomy without liver fragmentation was performed in a 60-year-old man with alcoholic liver cirrhosis and hepatocellular carcinoma. The explanted liver was retrieved through a suprapubic incision. A modified right liver graft, procured from his 24-year-old son using the pure laparoscopic method, was inserted through a suprapubic incision, and implantation was performed intracorporeally throughout the procedure. The time required to remove the liver was 369 minutes, and the total operative time was 960 min. No complications occurred during or after the surgery. The patient recovered well, and his hospital stay was of 11 days. Pure laparoscopic living donor liver transplantation from explant hepatectomy to implantation was performed successfully. It is a feasible procedure when performed by a highly experienced surgeon and transplantation team. Further studies with larger sample sizes are needed to confirm its safety and feasibility.

1 June 2014 in Journal of Hepatology
Verified
Journal Article
Closed access
SSSuk-Won Suh
Suk-Won Suh
KLKwang-Woong Lee
Kwang-Woong Lee
TYTae You
Tae You
YCYoungRok Choi
YoungRok Choi
HKHyeyoung Kim
Hyeyoung Kim
KSKyung-Suk Suh
Kyung-Suk Suh